Australian Dementia
Research Forum 2023

29 - 31 May 2023
Gold Coast, Queensland, Australia

Discovery, Diagnostics and Management:
A new era for Dementia

OPPORTUNITY TO PARTNER WITH US

Our sponsors and exhibitors are an integral and essential component of our discipline. The ADRF 2023 will be providing a unique opportunity for all those involved in the dementia network of prevention, treatment and care to come together to share knowledge, engage and connect. Your involvement will allow optimum exposure for your company and products.

To find out more about the packages available, please download the prospectus below or contact:

Alida Apostoloudas at alida.a@unimelb.edu.au for further information.

DOWNLOAD PROSPECTUS

DOWNLOAD TERMS AND CONDITIONS

MEDIA OPPORTUNITIES

Rates of Dementia Expected to Reach 1M by 2058

In Australia, the number of persons with dementia is expected to reach 1 million by 2058, but the good news is that research discoveries are accelerating with new treatments for Alzheimer’s disease and accurate diagnostic blood tests, now emerging.

From 29 - 31 May 2023, the world’s top dementia researchers, health professionals and policymakers, along with people living with dementia and their families and carers, will gather at the Marriott Gold Coast Resort & Spa, Queensland for the annual Australian Dementia Research Forum (ADRF 2023).

DOWNLOAD THE FULL MEDIA RELEASE

Understanding Dementia: Alzheimer’s Disease And Beyond

Although many Australians may be familiar with Alzheimer's disease, (the most common cause of dementia in Australia, accounting for about 60-80% of cases), there are other types of dementia as well. In recent years, frontotemporal dementia (FTD) has come to global attention, first with the Monty Python star, Terry Jones, dying from this disease in 2020, and most recently with the sombre announcement that the seemingly invincible action superstar Bruce Willis has been diagnosed with FTD.

FTD is a progressive and irreversible neurological disorder that affects the frontal and temporal lobes of the brain, and can cause changes in personality, behaviour, language and movement skills and also impacts decision-making and other executive functions.

DOWNLOAD THE FULL MEDIA RELEASE

THANK YOU TO OUR SPONSORS

Platinum Partner

The Australian Government Department of Health and Aged Care develops and delivers policies and programs on health, aged care and sport. We work with a wide range of stakeholders to ensure better health and wellbeing for all Australians.

The department is responsible for administering aged care legislation and developing policy that supports high quality, safe and affordable aged care.

We deliver a broad range of programs relating to aged care, including the Commonwealth Home Support Program (CHSP), and funding for residential aged care. We also support people to navigate and access aged care services through My Aged Care.

The Royal Commission into Aged Care Quality and Safety final report challenges us to create better aged care services and a better standard of care for older people.

In response, the Australian Government is committed to making changes to aged care to deliver safety, dignity and quality in care for every older person across our aged care system.

To find out more, and to contribute to upcoming changes, visit the Aged Care Engagement Hub: www.agedcareengagement.health.gov.au or call 1800 200 422.

Gold Sponsor

Dementia Australia is the source of trusted information, education and services for the estimated half a million Australians living with dementia, and the almost 1.6 million people involved in their care.

We advocate for positive change and support vital research. We are here to support people impacted by dementia, and to enable them to live as well as possible.

Founded by carers more than 35 years ago, today we are the national peak body for people living with dementia, their families and carers. We involve people impacted by dementia and their experiences in our activities and decision-making, to make sure we are representative of the diverse range of dementia experiences. We amplify the voices of people impacted by dementia through advocating and sharing stories to help inform and inspire others.

No matter how you are impacted by dementia or who you are, we are here for you.

Silver Sponsor

The Australian e-Health Research Centre (AEHRC) is CSIRO’s digital health research program. We have world leading capability in clinical image analysis; genomics data analytics; biostatistics; health data analytics; and data interoperability.

We work with collaborators across the healthcare system to improve diagnosis and treatment across Australia and internationally.

Silver Sponsor

Novo Nordisk is a global healthcare company, founded in 1923 and headquartered just outside Copenhagen, Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases, including Alzheimer’s disease, with an ambition to help people live longer, happier and healthier lives. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure the diseases we treat.

Silver Sponsor

Eisai are a global leading research-based pharmaceutical company working in the neurology and oncology therapeutic areas. Eisai’s corporate mission is to give first thought to patients and their families, and to increase the benefits health care provides.

Networking Reception Sponsor

Actinogen is conducting Phase 2 trials in people with early-stage Alzheimer’s Disease and cognitive impairment associated with Depression. Xanamem®, is a promising oral therapy with positive clinical data from three placebo-controlled trials.
For more information visit www.actinogen.com.au

® Xanamem is a registered trademark of Actinogen Medical Limited

Bronze Exhibition Sponsors